Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility

Journal of Biological Chemistry

Volumn 289, Issue 9, 2014, Pages 5904-5913

  Zimmerman, Mark W ^a   McQueeney, Kelley E ^b   Isenberg, Jeffrey S ^a   Pitt, Bruce R ^a,c   Wasserloos, Karla A ^c   Homanics, Gregg E ^a   Lazo, John S ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL EVIDENCE; HUMAN ENDOTHELIAL CELLS; MICROVESSEL DENSITY; PROTEIN-TYROSINE PHOSPHATASE; SMALL MOLECULE INHIBITOR; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR PERMEABILITY; WOUND HEALING ASSAYS;

AMINO ACIDS; CELL ENGINEERING; CYTOLOGY; HISTOLOGY; MAMMALS; PHOSPHATASES; PROTEINS; TUMORS;

ENDOTHELIAL CELLS;

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 4A3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY DENSITY; CELL INVASION; CELL ISOLATION; CELL MOTILITY; COLON TUMOR; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANGIOGENESIS; CANCER; ENDOTHELIAL CELL; ENDOTHELIUM; PHOSPHATASE; PTP4A3 (PRL-3); SRC; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF); VASCULAR PERMEABILITY;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; COLONIC NEOPLASMS; ENDOTHELIAL CELLS; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, MUTANT STRAINS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN TYROSINE PHOSPHATASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896809295     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.480038     Document Type: Article

References (39)

1. Zeng, Q., Si, X., Horstmann, H., Xu, Y., Hong, W., and Pallen, C. J. (2000) Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem. 275, 21444-21452 (Pubitemid 30481847)
2. Zimmerman, M. W., Homanics, G. E., and Lazo, J. S. (2013) Targeted deletion of the metastasis-associated phophatase Ptp4a3 (PRL-3) suppresses murine colon cancer. PLoS One 8, e58300
3. Stephens, B. J., Han, H., Gokhale, V., and Von Hoff, D. D. (2005) PRL phosphatases as potential molecular targets in cancer. Mol. Cancer Ther. 4, 1653-1661 (Pubitemid 41685299)
4. Radke, I., Götte, M., Kersting, C., Mattsson, B., Kiesel, L., and Wülfing, P. (2006) Expression and prognostic impact of the protein-tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br. J. Cancer 95, 347-354 (Pubitemid 44187596)
5. Molleví, D. G., Aytes, A., Padullés, L., Martínez-Iniesta, M., Baixeras, N., Salazar, R., Ramos, E., Figueras, J., Capella, G., and Villanueva, A. (2008) PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. Br. J. Cancer 99, 1718-1725
6. Wang, H., Quah, S. Y., Dong, J. M., Manser, E., Tang, J. P., and Zeng, Q. (2007) PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res. 67, 2922-2926 (Pubitemid 46724825)
7. Liang, F., Liang, J., Wang, W. Q., Sun, J. P., Udho, E., and Zhang, Z. Y. (2007) PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J. Biol. Chem. 282, 5413-5419 (Pubitemid 47093772)
8. Ming, J., Liu, N., Gu, Y., Qiu, X., and Wang, E. H. (2009) PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Pathology 41, 118-126
9. Fiordalisi, J. J., Keller, P. J., and Cox, A. D. (2006) PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 66, 3153-3161
10. St Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., and Kinzler, K. W. (2000) Genes expressed in human tumor endothelium. Science 289, 1197-1202 (Pubitemid 30650733)
11. Bardelli A., Saha, S., Sager, J. A., Romans, K. E., Xin, B., Markowitz, S. D., Lengauer, C., Velculescu, V. E., Kinzler, K. W., and Vogelstein, B. (2003) PRL-3 expression in metastatic cancers. Clin. Cancer Res. 9, 5607-5615 (Pubitemid 37499481)
12. Parker, B. S., Argani, P., Cook, B. P., Liangfeng, H., Chartrand, S. D., Zhang, M., Saha, S., Bardelli, A., Jiang, Y., St Martin, T. B., Nacht, M., Teicher, B. A., Klinger, K. W., Sukumar, S., and Madden, S. L. (2004) Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res. 64, 7857-7866 (Pubitemid 39446919)
13. Guo, K., Li, J., Wang, H., Osato, M., Tang, J. P., Quah, S. Y., Gan, B. Q., and Zeng, Q. (2006) PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Res. 66, 9625-9635 (Pubitemid 44623662)
14. Rouleau, C., Roy, A., St Martin, T., Dufault, M. R., Boutin, P., Liu, D., Zhang, M., Puorro-Radzwill, K., Rulli, L., Reczek, D., Bagley, R., Byrne, A., Weber, W., Roberts, B., Klinger, K., Brondyk, W., Nacht, M., Madden, S., Burrier, R., Shankara, S., and Teicher, B. A. (2006) Protein-tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol. Cancer Ther. 5, 219-229
15. Xu, J., Cao, S., Wang, L., Xu, R., Chen, G., and Xu, Q. (2011) VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C. PLoS One 6, e27165
16. He, H., Venema, V. J., Gu, X., Venema, R. C., Marrero, M. B., and Caldwell, R. B. (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J. Biol. Chem. 274, 25130-25135
17. Rousseau, S., Houle, F., Landry, J., and Huot, J. (1997) p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15, 2169-2177 (Pubitemid 27493906)
18. Fagerli, U. M., Holt, R. U., Holien, T., Vaatsveen, T. K., Zhan, F., Egeberg, K. W., Barlogie, B., Waage, A., Aarset, H., Dai, H. Y., Shaughnessy, J. D., Jr., Sundan, A., and Børset, M. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood 111, 806-815
19. Fiordalisi, J. J., Dewar, B. J., Graves, L. M., Madigan, J. P., and Cox, A. D. (2013) Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion. PLoS One 8, e64309
20. Ooki, A., Yamashita, K., Kikuchi, S., Sakuramoto, S., Katada, N., Waraya, M., Kawamata, H., Nishimiya, H., Nakamura, K., and Watanabe, M. (2011) Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. BMC Cancer 11, 122
21. Isenberg, J. S., Ridnour, L. A., Perruccio, E. M., Espey, M. G., Wink, D. A., and Roberts, D. D. (2005) Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 102, 13141-13146 (Pubitemid 41324992)
22. Tyurina, Y. Y., Tyurin, V. A., Kapralova, V. I., Wasserloos, K., Mosher, M., Epperly, M. W., Greenberger, J. S., Pitt, B. R., and Kagan, V. E. (2011) Oxidative lipidomics of γ-radiation-induced lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Radiat. Res. 175, 610-621
23. Thompson, H. J., McGinley, J. N., Knott, K. K., Spoelstra, N. S., and Wolfe, P. (2002) Vascular density profile of rat mammary carcinomas induced by 1-methyl-1-nitrosourea: implications for the investigation of angiogenesis. Carcinogenesis 23, 847-854 (Pubitemid 34567525)
24. Preusser, M., Heinzl, H., Gelpi, E., Schonegger, K., Haberler, C., Birner, P., Marosi, C., Hegi, M., Gorlia, T., Hainfellner, J. A., and European Organization for Research and Treatment of Cancer Brain Tumor Group (2006) Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer 107, 162-170 (Pubitemid 43939043)
25. Liu, H., Omer Al-aidaroos, A. Q., Wang, H., Guo, K., Li, J., Zhang, H. F., and Zeng, Q. (2013) PRL-3 suppresses c-FOS and integrin a2 expression in ovarian cancer cells. BMC Cancer 13, 80
26. Ahn, J. H., Kim, S. J., Park, W. S., Cho, S. Y., Ha, J. D., Kim, S. S., Kang, S. K., Jeong, D. G., Jung, S. K., Lee, S. H., Kim, H. M., Park, S. K., Lee, K. H., Lee, C. W., Ryu, S. E., and Choi, J. K. (2006) Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorg. Med. Chem. Lett. 16, 2996-2999
27. Min, G., Lee, S. K., Kim, H. N., Han, Y. M., Lee, R. H., Jeong, D. G., Han, D. C., and Kwon, B. M. (2013) Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells. Bioorg. Med. Chem. Lett. 23, 3769-3774
28. Nagy, J. A., Dvorak, A. M., and Dvorak, H. F. (2012) Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb. Perspect. Med. 2, a006544
29. Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., and Cheresh, D. A. (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4, 915-924 (Pubitemid 30054898)
30. Sun, Z., Li, X., Massena, S., Kutschera, S., Padhan, N., Gualandi, L., Sundvold-Gjerstad, V., Gustafsson, K., Choy, W. W., Zang, G., Quach, M., Jansson, L., Phillipson, M., Abid, M. R., Spurkland, A., and Claesson-Welsh, L. (2012) VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J. Exp. Med. 209, 1363-1377
31. Miles, A. A., and Miles, E. M. (1952) Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea pigs. J. Physiol. 118, 228-257
32. Auerbach, R., Akhtar, N., Lewis, R. L., and Shinners, B. L. (2000) Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev. 19, 167-172 (Pubitemid 32004706)
33. Lian, S., Meng, L., Liu, C., Xing, X., Song, Q., Dong, B., Han, Y., Yang, Y., Peng, L., Qu, L., and Shou, C. (2013) PRL-3 activates NF-κB signaling pathway by interacting with RAP1. Biochem. Biophys. Res. Commun. 430, 196-201
34. Al-Aidaroos, A. Q., Yuen, H. F., Guo, K., Zhang, S. D., Chung, T. H., Chng, W. J., and Zeng, Q. (2013) Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells. J. Clin. Invest. 123, 3459-3471
35. Zeng, Q., Dong, J. M., Guo, K., Li, J., Tan, H. X., Koh, V., Pallen, C. J., Manser, E., and Hong, W. (2003) PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. 63, 2716-2722 (Pubitemid 36667138)
36. Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., Ferrara, N., Fyfe, G., Rogers, B., Ross, R., and Kabbinavar, F. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335-2342 (Pubitemid 38702844)
37. Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., and Johnson, D. H. (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N. Engl. J. Med. 355, 2542-2550 (Pubitemid 44917502)
38. Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., Rolland, F., Demkow, T., Hutson, T. E., Gore, M., Freeman, S., Schwartz, B., Shan, M., Simantov, R., and Bukowski, R. M. (2007) Sorafenib in advanced clear-cell renal cell carcinoma. N. Engl. J. Med. 356, 125-134 (Pubitemid 46089673)
39. Casanovas, O., Hicklin, D. J., Bergers, G., and Hanahan, D. (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299-309 (Pubitemid 41443415)